Jeffrey H. Buchalter
2007
In 2007, Jeffrey H. Buchalter earned a total compensation of $5.3M as President and Chief Executive Officer at Enzon Pharmaceuticals, a 38% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,162,500 |
|---|---|
| Option Awards | $2,136,283 |
| Salary | $773,558 |
| Stock Awards | $974,657 |
| Other | $208,495 |
| Total | $5,255,493 |
Buchalter received $2.1M in option awards, accounting for 41% of the total pay in 2007.
Buchalter also received $1.2M in non-equity incentive plan, $773.6K in salary, $974.7K in stock awards and $208.5K in other compensation.
Rankings
In 2007, Jeffrey H. Buchalter's compensation ranked 759th out of 8,700 executives tracked by ExecPay. In other words, Buchalter earned more than 91.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 759 out of 8,700 | 91st |
Division Manufacturing | 249 out of 3,314 | 93rd |
Major group Chemicals And Allied Products | 52 out of 746 | 93rd |
Industry group Drugs | 32 out of 546 | 94th |
Industry Biological Products, Except Diagnostic Substances | 3 out of 118 | 98th |
Source: SEC filing on April 16, 2008.
Buchalter's colleagues
We found four more compensation records of executives who worked with Jeffrey H. Buchalter at Enzon Pharmaceuticals in 2007.
2007
Ivan Horak
Enzon Pharmaceuticals
Chief Scientific Officer
2007
Craig Tooman
Enzon Pharmaceuticals
Chief Financial Officer
2007
Ralph del Campo
Enzon Pharmaceuticals
Executive Vice President, Technical Operations
2007
Paul Davit
Enzon Pharmaceuticals